When the clinical stage of ESCC in patients was classified into stage I to IV according to the TNM classification, stage I and II tumors showed significantly higher percentages of SLC39A6-positive cells compared with stages III and IV tumors in the Kazakh population (P = 0.026). The gene discussed is SLC39A6; the disease is esophageal squamous cell carcinoma.